Ifp Advisors, Inc Gilead Sciences, Inc. Transaction History

Ifp Advisors, Inc

$2.42 Billion
Q2 2024

A detailed history of Ifp Advisors, Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 7,183 shares of GILD stock, worth $632,678. This represents 0.02% of its overall portfolio holdings.

Number of Shares

7,183

Previous 10,232 29.8%

Holding current value

$632,678

Previous $749,000 34.31%

% of portfolio

0.02%

Previous 0.03%

35 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	SELL	$63.15 - $72.88 $192,544 - $222,211	-3,049 Reduced 29.8%	7,183 $492,000
Q1 2024 Jul 30, 2024	BUY	$71.58 - $87.29 $51,752 - $63,110	723 Added 7.6%	10,232 $749,000
Q4 2023 Jan 09, 2024	BUY	$73.27 - $83.09 $46,453 - $52,679	634 Added 7.14%	9,509 $770,000
Q3 2023 Oct 12, 2023	SELL	$73.94 - $80.67 $170,431 - $185,944	-2,305 Reduced 20.62%	8,875 $665,000
Q2 2023 Aug 04, 2023	SELL	$76.01 - $86.7 $122,908 - $140,193	-1,617 Reduced 12.64%	11,180 $861,000
Q1 2023 Apr 18, 2023	SELL	$77.31 - $88.08 $2.75 Million - $3.13 Million	-35,557 Reduced 73.53%	12,797 $1.06 Million
Q4 2022 Feb 07, 2023	SELL	$62.32 - $89.47 $324,562 - $465,959	-5,208 Reduced 9.72%	48,354 $4.36 Million
Q3 2022 Nov 08, 2022	BUY	$59.54 - $68.01 $323,718 - $369,770	5,437 Added 11.3%	53,562 $4.83 Million
Q2 2022 Sep 06, 2022	BUY	$57.72 - $65.01 $2.76 Million - $3.11 Million	47,874 Added 19073.31%	48,125 $4.34 Million
Q2 2022 Aug 12, 2022	SELL	$57.72 - $65.01 $2.76 Million - $3.11 Million	-47,874 Reduced 99.48%	251 $23,000
Q1 2022 Sep 06, 2022	BUY	$57.92 - $72.58 $1.44 Million - $1.81 Million	24,879 Added 107.02%	48,125 $2.86 Million
Q1 2022 Aug 08, 2022	SELL	$57.92 - $72.58 $99,216 - $124,329	-1,713 Reduced 6.86%	23,246 $1.38 Million
Q4 2021 Jan 12, 2022	BUY	$64.88 - $73.64 $1.02 Million - $1.16 Million	15,715 Added 170.0%	24,959 $1.85 Million
Q3 2021 Oct 06, 2021	BUY	$67.69 - $73.03 $26,399 - $28,481	390 Added 4.4%	9,244 $645,000
Q2 2021 Jul 13, 2021	BUY	$63.47 - $69.35 $145,282 - $158,742	2,289 Added 34.87%	8,854 $607,000
Q1 2021 Apr 30, 2021	SELL	$60.0 - $68.46 $229,440 - $261,791	-3,824 Reduced 36.81%	6,565 $423,000
Q4 2020 Jan 25, 2021	SELL	$56.65 - $64.55 $39,938 - $45,507	-705 Reduced 6.35%	10,389 $608,000
Q3 2020 Oct 29, 2020	SELL	$62.1 - $78.08 $52,474 - $65,977	-845 Reduced 7.08%	11,094 $706,000
Q2 2020 Aug 05, 2020	BUY	$72.34 - $84.0 $145,041 - $168,420	2,005 Added 20.18%	11,939 $886,000
Q1 2020 May 12, 2020	BUY	$62.63 - $80.22 $300,686 - $385,136	4,801 Added 93.53%	9,934 $737,000
Q4 2019 Jan 17, 2020	SELL	$61.62 - $67.78 $317,897 - $349,677	-5,159 Reduced 50.13%	5,133 $340,000
Q3 2019 Nov 07, 2019	BUY	$62.51 - $69.0 $226,723 - $250,263	3,627 Added 54.42%	10,292 $654,000
Q1 2019 May 15, 2019	SELL	$62.53 - $70.05 $674,386 - $755,489	-10,785 Reduced 61.81%	6,665 $438,000
Q4 2018 Jan 23, 2019	SELL	$60.54 - $79.0 $269,524 - $351,708	-4,452 Reduced 20.33%	17,450 $1.09 Million
Q3 2018 Oct 25, 2018	SELL	$71.28 - $78.92 $89,171 - $98,728	-1,251 Reduced 5.4%	21,902 $0
Q2 2018 Aug 07, 2018	SELL	$64.88 - $75.68 $237,979 - $277,594	-3,668 Reduced 13.68%	23,153 $0
Q1 2018 Jun 03, 2019	SELL	$72.84 - $88.8 $108,604 - $132,400	-1,491 Reduced 5.27%	26,821 $1.92 Million
Q1 2018 May 09, 2018	BUY	$72.84 - $88.8 $108,604 - $132,400	1,491 Added 5.56%	28,312 $0
Q4 2017 Jan 24, 2018	SELL	$71.15 - $83.52 $679,482 - $797,616	-9,550 Reduced 26.26%	26,821 $0
Q3 2017 Oct 30, 2017	BUY	$72.11 - $85.47 $207,965 - $246,495	2,884 Added 8.61%	36,371 $2.95 Million
Q2 2017 Jun 03, 2019	BUY	N/A	5,144 Added 18.15%	33,487 $2.37 Million
Q1 2017 Jun 03, 2019	SELL	N/A	-741 Reduced 2.55%	28,343 $1.93 Million
Q4 2016 Jun 03, 2019	BUY	N/A	733 Added 2.59%	29,084 $2.08 Million
Q2 2016 Jun 03, 2019	BUY	N/A	21,686 Added 325.37%	28,351 $2.37 Million
Q1 2016 Jun 03, 2019	BUY	N/A	6,665	6,665 $438,000

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.04M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account